Your browser doesn't support javascript.
loading
Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.
Villena, Rodolfo; Safadi, Marco Aurelio P; Valenzuela, María Teresa; Torres, Juan P; Finn, Adam; O'Ryan, Miguel.
Affiliation
  • Villena R; a Department of Pediatrics , Hospital de Niños Exequiel González Cortés, Facultad de Medicina, Universidad de Chile , Santiago , Chile.
  • Safadi MAP; b Department of Pediatrics , Santa Casa de São Paulo School of Medical Sciences , São Paulo , Brazil.
  • Valenzuela MT; c Department of Epidemiology and Public Health , Universidad de Los Andes , Santiago , Chile.
  • Torres JP; d Department of Pediatrics , Hospital Luis Calvo Mackenna, Facultad de Medicina, Universidad de Chile , Santiago , Chile.
  • Finn A; e Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol , United Kingdom.
  • O'Ryan M; f Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile , Santiago , Chile.
Hum Vaccin Immunother ; 14(5): 1042-1057, 2018 05 04.
Article in En | MEDLINE | ID: mdl-29667483
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease Outbreaks / Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Global Burden of Disease / Meningococcal Infections Type of study: Prevalence_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Hum Vaccin Immunother Year: 2018 Document type: Article Affiliation country: Chile
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease Outbreaks / Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Global Burden of Disease / Meningococcal Infections Type of study: Prevalence_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Hum Vaccin Immunother Year: 2018 Document type: Article Affiliation country: Chile